This research challenges the prevailing belief that chromosomal changes that cause cancer occur gradually over extended periods of time. Instead suggesting they occur in short, punctuated “bursts” at the earliest stages of tumor growth.
Cancer and the treatments prescribed to fight it can weaken patients’ bones, leading to bone loss and fractures. Researchers in MD Anderson’s Bone Health Clinic are developing new interventions to reduce this.
A study conducted at MD Anderson has shown that a protein called ZMYND8 inhibits metastasis-linked genes in prostate cancer. Understanding what causes metastasis and how to prevent it could lead to the development of novel treatments.